Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of Emergence Delirium in Children Undergoing Squint Surgery
NCT07057193Active, not recruiting
- Sponsor
- Zagazig University
- Start
- Jan 2026
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine, ketamine and midazolam in emergence delirium (ED) (4 arms), sponsored by Zagazig University. Primary endpoint: Incidence and severity of Emergence Delirium. Started Jan 2026; status: active, not recruiting.
02
Drugs
dexmedetomidineketaminemidazolam
03
Conditions
emergence delirium (ED)
Beyond the preview
Go deeper on NCT07057193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07057193.